A major concern for all ophthalmic trainees is the progression of our surgical skills and abilities. The best methods for surgical training and optimizing performance remain unclear. Jack S. Parker, MD, shares his views on this and tells us why even th…
Home monitoring with a preferential hyperacuity perimetry device may allow for early detection of choroidal neovascularization-related changes in patients with early age-related macular degeneration.The earlier neovascular AMD is treated, the better fi…
Almost 1,800 subjects have been enrolled in the French FEMCAT study evaluating the clinical value and cost-effectiveness of femtosecond laser-assisted cataract surgery, a speaker said at the European Society of Cataract and Refractive Surgeons meeting in Barcelona.The study will be completed in the first half of 2016. It is designed to provide a scientific basis for the potential adoption of femtosecond laser-assisted cataract surgery in the French health care system, Béatrice Cochener, MD, PhD, said.
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Russ Trenary, president and CEO of InnFocus, discusses 3-year study results published in the Journal of Glaucoma of the efficacy of the InnFocus microshunt for lowering IOP — alone, with mitomycin C or in combination with phacoemulsification.
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that it has established a direct sales organization and launched the iStent inject® Trabecular Micro-Bypass Stent in Australia. The iStent inject is approved by the Australian Therapeutics Goods Administration for use in conjunctio
SEATTLE–(BUSINESS WIRE)–KPI Therapeutics initiates two new lines of research